NR3C1 and invasive breast carcinoma: However, despite the fact that GR expression in mammary tissue declines from normal to precancerous lesions and to invasive breast carcinoma (54, 78), the increment in stress hormones during breast cancer progression results in GR activation even at distant metastatic sites.